Correlation Between Novo Nordisk and Cessatech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Cessatech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Cessatech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Cessatech AS, you can compare the effects of market volatilities on Novo Nordisk and Cessatech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Cessatech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Cessatech.

Diversification Opportunities for Novo Nordisk and Cessatech

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Novo and Cessatech is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Cessatech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cessatech AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Cessatech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cessatech AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Cessatech go up and down completely randomly.

Pair Corralation between Novo Nordisk and Cessatech

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Cessatech. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 2.24 times less risky than Cessatech. The stock trades about -0.15 of its potential returns per unit of risk. The Cessatech AS is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  1,440  in Cessatech AS on September 2, 2024 and sell it today you would lose (85.00) from holding Cessatech AS or give up 5.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy33.33%
ValuesDaily Returns

Novo Nordisk AS  vs.  Cessatech AS

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Cessatech AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cessatech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Novo Nordisk and Cessatech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Cessatech

The main advantage of trading using opposite Novo Nordisk and Cessatech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Cessatech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cessatech will offset losses from the drop in Cessatech's long position.
The idea behind Novo Nordisk AS and Cessatech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk